Navigation Links
S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
Date:8/31/2007

COLUMBIA, S.C., Aug. 31 /PRNewswire/ -- BlueCross BlueShield of South Carolina has created a new division called Corporate Planning and Strategic Services and promoted Jill Davis to vice president in charge of the unit.

The division head reports directly to CEO M. Edward Sellers and is responsible for enhancing the company's long-term, strategic planning efforts and for formalizing a corporate-wide executive development program.

"We are creating this new division because of the growth and expanded diversity and scale of operations our company has experienced over the past decade," said Sellers. "Growth brings new challenges. In this new division, we will look to better integrate the plans and goals of our many business units, and to better track achievement of those goals at the corporate level."

The new unit also will work with the Human Resources department in the long-term development of the company's future senior managers.

Davis joined BlueCross BlueShield in 1996 as a project leader in the Information Systems department, where she led long-range systems development projects. In 1999, she joined the corporate executive area as special assistant to the CEO, where she assumed managerial, administrative and analytical duties in support of the CEO's office. She holds a bachelor's degree in computer science from Rutgers University and a master's in business administration from the University of Virginia's Darden School of Business. Her previous employers include Philip Morris USA, Spectrum Consulting Group, and Dow Jones & Company, Inc.

Headquartered in Columbia, S.C., BlueCross BlueShield of South Carolina (http://www.SouthCarolinaBlues.com) is an independent licensee of the Blue Cross and Blue Shield Association. BlueCross BlueShield of South Carolina and its family of companies include more than 20 subsidiaries involved in health insurance services, U.S. DOD health
'/>"/>

SOURCE BlueCross BlueShield of South Carolina
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Plague creates panic in India
2. Experiment Creates Illusion Of Weight Loss
3. Death Of Woman Following Family Planning Operation Creates Panic
4. Resistant Influenza strains creates panic in US
5. Measles Outbreak In Bihar Creates Panic
6. Suspected Bird Flu Death Creates Panic In Hong Kong
7. Male Students Entry in Womens College Creates Furore in Pakistan Assembly
8. Domino Transplants Creates new wave In the Field Of Kidney Transplantation
9. MIT Creates 3-D Scaffold for Growing Stem Cells
10. Dog’s Death During Demonstration Creates Uproa
11. AIIMS Creates Record by Completing 100 Four-arm Robotic Surgeries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... , Brain perfusion applic...nterprise using the Ziostation® thin-client sy...if (PRWEB) January 8, 2009 -- Ziosoft®, Inc. ...software for medical imaging , today announced th...Food and Drug Administration (FDA) for its CT brai...
(Date:1/7/2009)... , SEATTLE, Jan. 8 Ce... announced today that they received $7.5 million p...trum Pharmaceuticals, Inc. to commercialize and de..., the Company received the initial $7.5 million pa...action. The Company may earn up to an additional ...
(Date:1/7/2009)... , BOSTON The drive toward containing health ca...reducing physician productivity, impairing quality...l Deaconess Medical Center physicians suggest in a..., Citing studies in behavioral economics and psyc...D, express the fear that assigning a monetary valu...
(Date:1/7/2009)... , SAN MARCOS, Calif., Jan, 7 Natural Alternative... leading formulator, manufacturer and marketer of ...d that effective December 31, 2008 its former Pres... , , NAI also announced it completed certain amen...k. Among other changes the amendments extend the ...
Breaking Medicine News(10 mins):Health News:Ziosoft Receives FDA Clearance for CT Brain Perfusion Application 2Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 2Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 3Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 4Health News:Cost containment focus could have consequences for health care delivery 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2
...high cholesterol levels are more likely to develop.... Researchers studied the eating habits and choles...about five years. The children were examined by do...ol, and LDL, or bad cholesterol, measured periodic...
...e that male babies who grow slowly in their first ... results hold true regardless of the socioeconomic...w infant growth may be accompanied by hampered bra...oor growth in infancy lead to lifelong impairment ...
...solved the puzzle of why baby boys are so much big...ring pregnancy. Women carrying male embryos consum...re protein and have a higher intake of carbohydrat...cepted that on average newborn boys are heavier th...
... the frequency of hot flashes in menopausal women,...gh an independent researcher said the drug's effec...rmone replacement therapy for menopausal symptoms ...sleep problems will be looked at more closely beca...
Other Medicine News:
(Date:1/6/2009)...RNewswire/ -- Pacira Pharmaceuticals, Inc., an,ac...ed today that enrollment,has been completed in tw...,safety and efficacy of a single intraoperative ad... prolonged postoperative analgesia. , Resul...al knee,arthroplasty (TKA) are expected to provid...
(Date:1/3/2009)...EMONT, Ill., Jan. 2 Mag...ogy providing an increasing number of clinical ben...ording to an article in the January 2009 issue of ... Surgeons ( http://www.jaaos.org/ ). It is predic...echnical developments will allow MRI to provide ev...
(Date:12/27/2008)...ar silence, offers to ease cloning costs for Clona...Dec. 27 Six years to th...d child, Dr. Brigitte Boisselier, head of the comp...ther babies cloned by her company are growing up h... families, privacy. , , "We,ve helped almost 10...
(Date:12/17/2008)...FirstCall/ -- Medivation, Inc.,(Nasdaq: MDVN ) ...llment in a,Phase 1-2 dose-escalation clinical tr...onist, in castration-resistant prostate cancer pat...S. Food and Drug Administration (FDA) to,advance ... open-label, U.S. Phase 1-2 study evaluated prosta...
Breaking Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3'We're Ready to Prove It!' 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday August 5 2008 24489 1Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday August 5 2008 24489 2DoctorDirectory to Co market VoSpire ER 28R 29 with DAVA Pharmaceuticals Inc 24486 1DoctorDirectory to Co market VoSpire ER 28R 29 with DAVA Pharmaceuticals Inc 24486 2InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 1InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 2InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 3Poniard Pharmaceuticals Announces Upcoming Conference Participation 6783 1Poniard Pharmaceuticals Announces Upcoming Conference Participation 6783 2
...., May 09, 2007 /PRNewswire-FirstCall/ --,Catalyst...itive,initial, top-line results from a bioequivale...igabatrin Tablets) is bioavailable and,bioequivale...rketed,in Europe by Sanofi Aventis. These data pot...e extensive body of published pre-clinical,and cli...
...if.--(BUSINESS WIRE)--May 10, 2007 - According to,...65 percent of,female respondents seeking treatment...Painkillers such as Vicodin, OxyContin, Percocet,a...n, 35 percent of,the mothers who reported a depend... to Clare Waismann, registered addiction,specialis...
Other Medicine Technology:Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 2Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 3Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 4Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2
Pneumatic impactor, general surgery, available in various hose connector styles.
The SmartDriver System consists of a pistol-grip handpiece available in Pneumatic, Electric and Battery Power, with a wide range of couplers that can be used in a variety of orthopedic surgical appli
Introducing the new large power line from MicroAire. Our new handpieces function as both cordless AND electric instruments, offering the ultimate in flexibility. Its the versatility the industry has
The 7600 Oscillating Saw offers unparalleled power for large bone osteotomies, thanks to its 14.4V NiMH Rechargeable Battery Pack. The cutting head may be rotated into 12 positions for cutting in any
Medicine Products: